Kneat
Limerick
About Kneat
Kneat develops and markets the next generation Kneat Gx software platform. Kneat Gx, enables an end-to-end paperless process for all Validations, Commissioning and Qualification, Production Execution and Quality Document Management. It allows users to electronically create, approve and execute all records, manage any exceptions and post approve the final executed records and reports in a controlled FDA 21 CFR Part 11 / EudraLex Annex 11 paperless compliant system. Users with correct permissions can collaborate and see everything in real time on any device. Kneat Gx helps Life Sciences to comply with the requirements of all global regulatory bodies such as the FDA, EMA, MHRA, ICH, WHO etcTheir customers are reporting greater data integrity, productivity improvements in excess of 100%, 50% reduction in cycle times and an overall higher compliance standard.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $106.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: cve:KSI
- Website: kneat.com
- Phone: +353-61-203826
Industries & Categories
Compliance, SaaS, Software
Social Profiles
Canonical: https://fsome.com/organization/kneat-62961 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.